salsolinol has been researched along with thiazolyl blue in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copeland, RL; Kanaan, YM; Leggett, YA; Taylor, RE; Tizabi, Y | 1 |
| Bollimuntha, S; Ebadi, M; Singh, BB | 1 |
| Melzig, MF; Wszelaki, N | 1 |
3 other study(ies) available for salsolinol and thiazolyl blue
| Article | Year |
|---|---|
Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Conotoxins; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoquinolines; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Nicotine; Tetrazolium Salts; Thiazoles | 2005 |
TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; Blotting, Western; Calcium; Cell Count; Cell Line, Tumor; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Isoquinolines; Microscopy, Confocal; Neuroblastoma; Proteins; Tetrazolium Salts; Thiazoles; Time Factors; TRPC Cation Channels | 2006 |
Research on an in vitro cell system for testing the neurotoxicity of kynurenine pathway metabolites.
Topics: Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Coloring Agents; Fluorescent Antibody Technique; Humans; Hydroxydopamines; Isoquinolines; Kynurenine; Neuroblastoma; Neurotoxins; Quinolinic Acid; Tetrazolium Salts; Thiazoles; Tretinoin | 2011 |